Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 4:10 PM View:  | Agios Pharmaceuticals, Inc. (AGIO) | 05-Mar-24 | Planned Option Sale | 4,156 | $32.57 | $135,361.00 | (7%) 57.94K to 53.78K | |
| 05-Mar-24 4:10 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-24 | Option Exercise | 8,500 | -- | -- | 17% 49.44K to 57.94K | |
| 24-Jan-24 4:20 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 24-Jan-24 | Planned Option Sale | 7,635 | $21.64 | $165,221.00 | (13%) 57.07K to 49.44K | |
| 24-Jan-24 4:20 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 20-Jan-24 | Option Exercise | 17,018 | -- | -- | 42% 40.05K to 57.07K | |
| 09-Jan-24 4:28 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 09-Jan-24 | Planned Option Sale | 12,066 | $22.99 | $277,397.00 | (23%) 52.12K to 40.05K | |
| 09-Jan-24 4:28 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 05-Jan-24 | Option Exercise | 25,527 | -- | -- | 96% 26.59K to 52.12K | |
| 10-Aug-23 4:07 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 08-Aug-23 | Option Exercise | 22,691 | -- | -- | 161% 14.08K to 36.77K | |
| 10-Aug-23 4:07 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 08-Aug-23 | Option Sale | 10,178 | $25.48 | $259,335.00 | (28%) 36.77K to 26.59K | |
| 30-Jun-23 4:05 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 30-Jun-23 | Option Sale | 11,449 | $28.36 | $324,694.00 | (45%) 25.53K to 14.08K | |
| 30-Jun-23 4:05 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 28-Jun-23 | Option Exercise | 25,528 | -- | -- | 100% 0 to 25.53K | |
| 23-Jul-21 4:42 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 21-Jul-21 | Disposition | 150,832 | -- | -- | (100%) 150.83K to 0 | |
| 16-Jul-21 10:00 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 14-Jul-21 | Grant | 60,144 | -- | -- | 66% 90.69K to 150.83K | |
| 09-Jun-21 4:52 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Jun-21 | Payment of Exercise | 1,086 | $177.00 | $192,222.00 | (1%) 91.77K to 90.69K | (1%) |
| 02-Mar-21 5:55 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-21 | Grant | 24,473 | -- | -- | 36% 67.3K to 91.77K | |
| 18-Dec-20 5:09 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 16-Dec-20 | Grant | 40,677 | -- | -- | 85% 48.02K to 88.7K | |
| 18-Dec-20 5:09 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 16-Dec-20 | Payment of Exercise | 21,395 | $157.96 | $3,379,550.00 | (24%) 88.7K to 67.3K | (14%) |
| 09-Jun-20 4:58 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Jun-20 | Payment of Exercise | 1,642 | $114.61 | $188,190.00 | (3%) 49.66K to 48.02K | (57%) |
| 03-Mar-20 6:18 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 02-Mar-20 | Payment of Exercise | 1,401 | $90.54 | $126,847.00 | (3%) 51.06K to 49.66K | (99%) |
| 03-Mar-20 6:18 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-20 | Grant | 10,880 | -- | -- | 27% 40.18K to 51.06K | |
| 10-Feb-20 4:58 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Feb-20 | Payment of Exercise | 1,594 | $102.97 | $164,134.00 | (4%) 41.78K to 40.18K | (75%) |
| 11-Jun-19 6:38 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Jun-19 | Payment of Exercise | 1,643 | $118.61 | $194,876.00 | (4%) 43.42K to 41.78K | (52%) |
| 05-Mar-19 8:19 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-19 | Grant | 9,428 | -- | -- | 28% 33.99K to 43.42K | |
| 04-Mar-19 5:36 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-19 | Payment of Exercise | 670 | $132.93 | $89,063.10 | (2%) 34.66K to 33.99K | (35%) |
| 11-Feb-19 6:20 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Feb-19 | Payment of Exercise | 1,596 | $119.57 | $190,834.00 | (4%) 36.26K to 34.66K | (50%) |
| 12-Jun-18 4:51 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Jun-18 | Market Sale | 1,645 | $118.53 | $194,982.00 | (4%) 37.9K to 36.26K | (52%) |
| 02-Mar-18 5:00 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-18 | Grant | 8,940 | -- | -- | 31% 28.96K to 37.9K | |
| 08-Feb-18 7:17 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Feb-18 | Market Sale | 1,651 | $116.31 | $192,028.00 | (5%) 30.61K to 28.96K | (55%) |
| 08-Feb-18 7:17 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Feb-18 | Grant | 15,894 | -- | -- | 108% 14.72K to 30.61K | |
| 09-Jun-17 6:35 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Jun-17 | Grant | 14,719 | -- | -- | 100% 0 to 14.72K | |
| 07-Jun-16 4:37 PM View: | Baxalta Inc (BXLT) | 03-Jun-16 | Grant | 2,881 | -- | -- | 4% 67.17K to 70.05K | |
| 07-Jun-16 4:37 PM View: | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 70,047 | -- | -- | (100%) 70.05K to 0 | |
| 08-Mar-16 4:56 PM View: | Baxalta Inc (BXLT) | 07-Mar-16 | Payment of Exercise | 267 | $39.74 | $10,610.60 | (< 1%) 67.3K to 67.03K | (16%) |
| 07-Mar-16 6:14 PM View: | Baxalta Inc (BXLT) | 04-Mar-16 | Payment of Exercise | 303 | $39.47 | $11,959.40 | (< 1%) 67.6K to 67.3K | (17%) |
| 07-Mar-16 6:14 PM View: | Baxalta Inc (BXLT) | 03-Mar-16 | Grant | 35,605 | -- | -- | 107% 33.33K to 68.94K | |
| 07-Mar-16 6:14 PM View: | Baxalta Inc (BXLT) | 03-Mar-16 | Payment of Exercise | 1,338 | $39.30 | $52,583.40 | (2%) 68.94K to 67.6K | (18%) |
| 17-Feb-16 9:10 PM View: | Baxalta Inc (BXLT) | 15-Feb-16 | Grant | 1,060 | -- | -- | 3% 32.81K to 33.87K | |
| 17-Feb-16 9:10 PM View: | Baxalta Inc (BXLT) | 15-Feb-16 | Payment of Exercise | 533 | $39.00 | $20,787.00 | (2%) 33.87K to 33.34K | (19%) |
| 13-Aug-15 5:49 PM View: | Baxalta Inc (BXLT) | 11-Aug-15 | Grant | 292 | -- | -- | < 1% 32.31K to 32.6K | |
| 06-Jul-15 8:46 PM View: | Baxalta Inc (BXLT) | 01-Jul-15 | Acquisition (other) | 32,308 | -- | -- | 100% 0 to 32.31K |